Page last updated: 2024-08-07 17:02:35
Bcl-2-like protein 1
A Bcl-2-like protein 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q07817]
Synonyms
Bcl2-L-1;
Apoptosis regulator Bcl-X
Research
Bioassay Publications (73)
Timeframe | Studies on this Protein(%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (16.44) | 29.6817 |
2010's | 49 (67.12) | 24.3611 |
2020's | 12 (16.44) | 2.80 |
Compounds (35)
Drugs with Inhibition Measurements
Drugs with Activation Measurements
Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
Development of Mcl-1 inhibitors for cancer therapy.European journal of medicinal chemistry, , Jan-15, Volume: 210, 2021
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Improved binding affinities of pyrrolidine derivatives as Mcl-1 inhibitors by modifying amino acid side chains.Bioorganic & medicinal chemistry, , 01-01, Volume: 25, Issue:1, 2017
Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Structural modification of luteolin from Flos Chrysanthemi leads to increased tumor cell growth inhibitory activity.Bioorganic & medicinal chemistry letters, , 08-01, Volume: 26, Issue:15, 2016
Design, synthesis and preliminary biological studies of pyrrolidine derivatives as Mcl-1 inhibitors.Bioorganic & medicinal chemistry, , Dec-15, Volume: 23, Issue:24, 2015
Design, synthesis and biological evaluation of 3-aryl-rhodanine benzoic acids as anti-apoptotic protein Bcl-2 inhibitors.Bioorganic & medicinal chemistry letters, , Nov-15, Volume: 25, Issue:22, 2015
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.Bioorganic & medicinal chemistry, , Apr-15, Volume: 23, Issue:8, 2015
BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.Journal of medicinal chemistry, , May-27, Volume: 53, Issue:10, 2010
Fragment-based deconstruction of Bcl-xL inhibitors.Journal of medicinal chemistry, , Mar-25, Volume: 53, Issue:6, 2010
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.Journal of medicinal chemistry, , Oct-14, Volume: 53, Issue:19, 2010
Interaction of kendomycin and semi-synthetic analogues with the anti-apoptotic protein Bcl-xl.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 18, Issue:21, 2008
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.Journal of medicinal chemistry, , Aug-09, Volume: 50, Issue:16, 2007
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.Journal of medicinal chemistry, , Oct-19, Volume: 49, Issue:21, 2006
Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins.Journal of medicinal chemistry, , Sep-25, Volume: 46, Issue:20, 2003
Clinical candidates modulating protein-protein interactions: The fragment-based experience.European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.Bioorganic & medicinal chemistry, , Apr-15, Volume: 23, Issue:8, 2015
SAR by interligand nuclear overhauser effects (ILOEs) based discovery of acylsulfonamide compounds active against Bcl-x(L) and Mcl-1.Journal of medicinal chemistry, , Sep-08, Volume: 54, Issue:17, 2011
Design, synthesis and preliminary bioactivity studies of indomethacin derivatives as Bcl-2/Mcl-1 dual inhibitors.Bioorganic & medicinal chemistry, , 07-01, Volume: 27, Issue:13, 2019
3-Substituted-N-(4-hydroxynaphthalen-1-yl)arylsulfonamides as a novel class of selective Mcl-1 inhibitors: structure-based design, synthesis, SAR, and biological evaluation.Journal of medicinal chemistry, , May-22, Volume: 57, Issue:10, 2014
Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leads.RSC medicinal chemistry, , Aug-17, Volume: 13, Issue:8, 2022
Hot-Spots of Mcl-1 Protein.Journal of medicinal chemistry, , 02-13, Volume: 63, Issue:3, 2020
Clinical candidates modulating protein-protein interactions: The fragment-based experience.European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.Journal of medicinal chemistry, , 04-12, Volume: 61, Issue:7, 2018
(+)- and (-)-Ecarlottones, Uncommon Chalconoids from Fissistigma latifolium with Pro-Apoptotic Activity.Journal of natural products, , 12-22, Volume: 80, Issue:12, 2017
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules.Journal of medicinal chemistry, , 02-09, Volume: 60, Issue:3, 2017
Design, synthesis, and activity evaluation of selective inhibitors of anti-apoptotic Bcl-2 proteins: The effects on the selectivity of the P1 pockets in the active sites.Bioorganic & medicinal chemistry letters, , 11-01, Volume: 26, Issue:21, 2016
Anacardic Acids from Knema hookeriana as Modulators of Bcl-xL/Bak and Mcl-1/Bid Interactions.Journal of natural products, , Apr-22, Volume: 79, Issue:4, 2016
A combination of in silico and SAR studies to identify binding hot spots of Bcl-xL inhibitors.Bioorganic & medicinal chemistry, , Apr-15, Volume: 23, Issue:8, 2015
Biased and unbiased strategies to identify biologically active small molecules.Bioorganic & medicinal chemistry, , Aug-15, Volume: 22, Issue:16, 2014
Endiandric acid analogues from Beilschmiedia ferruginea as dual inhibitors of Bcl-xL/Bak and Mcl-1/Bid interactions.Journal of natural products, , Jun-27, Volume: 77, Issue:6, 2014
Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL.Journal of medicinal chemistry, , Jul-11, Volume: 56, Issue:13, 2013
Structure-guided design of a selective BCL-X(L) inhibitor.Nature chemical biology, , Volume: 9, Issue:6, 2013
Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.Journal of medicinal chemistry, , Jul-12, Volume: 55, Issue:13, 2012
Design of Bcl-2 and Bcl-xL inhibitors with subnanomolar binding affinities based upon a new scaffold.Journal of medicinal chemistry, , May-24, Volume: 55, Issue:10, 2012
Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.Bioorganic & medicinal chemistry, , Jul-15, Volume: 20, Issue:14, 2012
An anthraquinone scaffold for putative, two-face Bim BH3 α-helix mimic.Journal of medicinal chemistry, , Dec-13, Volume: 55, Issue:23, 2012
Synthesis and biological activities of polyquinoline derivatives: new Bcl-2 family protein modulators.European journal of medicinal chemistry, , Volume: 57, 2012
Structure-activity relationship of selected polyphenol derivatives as inhibitors of Bax/Bcl-xL interaction.European journal of medicinal chemistry, , Volume: 51, 2012
Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.Bioorganic & medicinal chemistry letters, , Jan-01, Volume: 22, Issue:1, 2012
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity.Journal of medicinal chemistry, , Mar-24, Volume: 54, Issue:6, 2011
Biochemical and pharmacological profiling of the pro-survival protein Bcl-xL.Bioorganic & medicinal chemistry letters, , Sep-01, Volume: 21, Issue:17, 2011
Fragment-based deconstruction of Bcl-xL inhibitors.Journal of medicinal chemistry, , Mar-25, Volume: 53, Issue:6, 2010
Synthesis and biological activities of new di- and trimeric quinoline derivatives.Bioorganic & medicinal chemistry, , Oct-01, Volume: 18, Issue:19, 2010
3D-QSAR pharmacophore modeling and in silico screening of new Bcl-xl inhibitors.European journal of medicinal chemistry, , Volume: 45, Issue:11, 2010
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.Journal of medicinal chemistry, , Oct-14, Volume: 53, Issue:19, 2010
Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.Journal of medicinal chemistry, , Oct-08, Volume: 52, Issue:19, 2009
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL.Journal of medicinal chemistry, , Feb-22, Volume: 50, Issue:4, 2007
Sensitive fluorogenic substrates for sirtuin deacylase inhibitor discovery.European journal of medicinal chemistry, , Apr-15, Volume: 192, 2020
Fragment-based deconstruction of Bcl-xL inhibitors.Journal of medicinal chemistry, , Mar-25, Volume: 53, Issue:6, 2010
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.Journal of medicinal chemistry, , Oct-19, Volume: 49, Issue:21, 2006
Development of Mcl-1 inhibitors for cancer therapy.European journal of medicinal chemistry, , Jan-15, Volume: 210, 2021
Structure-Based Optimization of 3-Phenyl-Journal of medicinal chemistry, , 07-22, Volume: 64, Issue:14, 2021
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.European journal of medicinal chemistry, , Feb-25, Volume: 146, 2018
Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
[no title available]ACS medicinal chemistry letters, , Jun-10, Volume: 12, Issue:6, 2021
[no title available]Journal of medicinal chemistry, , 10-14, Volume: 64, Issue:19, 2021
Discovery and optimization of covalent Bcl-xL antagonists.Bioorganic & medicinal chemistry letters, , 12-01, Volume: 29, Issue:23, 2019
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Clinical candidates modulating protein-protein interactions: The fragment-based experience.European journal of medicinal chemistry, , Apr-01, Volume: 167, 2019
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.Journal of medicinal chemistry, , 04-12, Volume: 61, Issue:7, 2018
Design, synthesis and pharmacological evaluation of new acyl sulfonamides as potent and selective Bcl-2 inhibitors.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.European journal of medicinal chemistry, , Feb-25, Volume: 146, 2018
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Design, synthesis and evaluation of marinopyrrole derivatives as selective inhibitors of Mcl-1 binding to pro-apoptotic Bim and dual Mcl-1/Bcl-xL inhibitors.European journal of medicinal chemistry, , Jan-27, Volume: 90, 2015
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.Bioorganic & medicinal chemistry letters, , Jul-15, Volume: 24, Issue:14, 2014
Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins.Journal of medicinal chemistry, , Dec-12, Volume: 56, Issue:23, 2013
Fragment-based deconstruction of Bcl-xL inhibitors.Journal of medicinal chemistry, , Mar-25, Volume: 53, Issue:6, 2010
Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.Journal of medicinal chemistry, , Oct-14, Volume: 53, Issue:19, 2010
Anacardic Acids from Knema hookeriana as Modulators of Bcl-xL/Bak and Mcl-1/Bid Interactions.Journal of natural products, , Apr-22, Volume: 79, Issue:4, 2016
Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.Bioorganic & medicinal chemistry letters, , Nov-01, Volume: 24, Issue:21, 2014
A Dimeric sesquiterpenoid from a Malaysian Meiogyne as a new inhibitor of Bcl-xL/BakBH3 domain peptide interaction.Journal of natural products, , Mar-27, Volume: 72, Issue:3, 2009
Discovery of a selective and covalent small-molecule inhibitor of BFL-1 protein that induces robust apoptosis in cancer cells.European journal of medicinal chemistry, , Jun-05, Volume: 236, 2022
Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeleton.Bioorganic & medicinal chemistry, , 10-01, Volume: 47, 2021
Design, synthesis and biological evaluation of dual Bcl-2/Mcl-1 inhibitors bearing 2-(1H-indol-4-yl)benzoic acid scaffold.Bioorganic & medicinal chemistry letters, , 09-01, Volume: 47, 2021
Structure-Based Optimization of 3-Phenyl-Journal of medicinal chemistry, , 07-22, Volume: 64, Issue:14, 2021
Beyond the Rule of 5: Lessons Learned from AbbVie's Drugs and Compound Collection.Journal of medicinal chemistry, , 04-12, Volume: 61, Issue:7, 2018
Design, synthesis and pharmacological evaluation of new acyl sulfonamides as potent and selective Bcl-2 inhibitors.Bioorganic & medicinal chemistry, , 01-15, Volume: 26, Issue:2, 2018
Development of high potent and selective Bcl-2 inhibitors bearing the structural elements of natural product artemisinin.European journal of medicinal chemistry, , Nov-05, Volume: 159, 2018
Small-molecule Mcl-1 inhibitors: Emerging anti-tumor agents.European journal of medicinal chemistry, , Feb-25, Volume: 146, 2018
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules.Journal of medicinal chemistry, , 02-09, Volume: 60, Issue:3, 2017
hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.ACS chemical biology, , 02-17, Volume: 12, Issue:2, 2017
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.ACS medicinal chemistry letters, , Oct-09, Volume: 5, Issue:10, 2014
[no title available],
Trends in targeting Bcl-2 anti-apoptotic proteins for cancer treatment.European journal of medicinal chemistry, , Mar-15, Volume: 232, 2022
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Expanding the Cancer Arsenal with Targeted Therapies: Disarmament of the Antiapoptotic Bcl-2 Proteins by Small Molecules.Journal of medicinal chemistry, , 02-09, Volume: 60, Issue:3, 2017
Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XACS medicinal chemistry letters, , Oct-08, Volume: 11, Issue:10, 2020
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.Bioorganic & medicinal chemistry letters, , May-01, Volume: 26, Issue:9, 2016
Development of Mcl-1 inhibitors for cancer therapy.European journal of medicinal chemistry, , Jan-15, Volume: 210, 2021
The chemical biology of apoptosis: Revisited after 17 years.European journal of medicinal chemistry, , Sep-01, Volume: 177, 2019
Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.Journal of medicinal chemistry, , Nov-25, Volume: 53, Issue:22, 2010
Enables
This protein enables 5 target(s):
Target | Category | Definition |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
protein kinase binding | molecular function | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. [GOC:jl] |
identical protein binding | molecular function | Binding to an identical protein or proteins. [GOC:jl] |
BH3 domain binding | molecular function | Binding to a BH3 protein domain, present in Bcl-2 family members. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death. [PMID:11048732, PMID:12133724, PMID:9020082, PMID:9704409, Prosite:PS01259] |
BH domain binding | molecular function | Binding to a Bcl-2 homology (BH) protein domain. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains. [PMID:11048732, PMID:12133724, PMID:9020082, PMID:9704409] |
Located In
This protein is located in 10 target(s):
Target | Category | Definition |
cytoplasm | cellular component | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. [ISBN:0198547684] |
mitochondrion | cellular component | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. [GOC:giardia, ISBN:0198506732] |
mitochondrial outer membrane | cellular component | The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. [GOC:ai] |
mitochondrial inner membrane | cellular component | The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae. [GOC:ai] |
mitochondrial matrix | cellular component | The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation. [GOC:as, ISBN:0198506732] |
endoplasmic reticulum | cellular component | The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached). [ISBN:0198506732] |
centrosome | cellular component | A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle. [GOC:mah, ISBN:0198547684] |
cytosol | cellular component | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. [GOC:hjd, GOC:jl] |
synaptic vesicle membrane | cellular component | The lipid bilayer surrounding a synaptic vesicle. [GOC:mah] |
nuclear membrane | cellular component | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. [GOC:mah, GOC:pz] |
Active In
This protein is active in 1 target(s):
Target | Category | Definition |
mitochondrial outer membrane | cellular component | The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope. [GOC:ai] |
Part Of
This protein is part of 1 target(s):
Target | Category | Definition |
Bcl-2 family protein complex | cellular component | A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed. [GOC:so, PMID:14634621] |
Involved In
This protein is involved in 41 target(s):
Target | Category | Definition |
ovarian follicle development | biological process | The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure. [https://www.ncbi.nlm.nih.gov/books/NBK279054/] |
in utero embryonic development | biological process | The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus. [GOC:go_curators, GOC:mtg_sensu] |
release of cytochrome c from mitochondria | biological process | The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation. [GOC:add, GOC:mah, GOC:mtg_apoptosis, ISBN:0721639976, PMID:12925707, PMID:9560217] |
endocytosis | biological process | A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a part of the plasma membrane to form a new membrane-bounded vesicle. [GOC:mah, ISBN:0198506732, ISBN:0716731363, Wikipedia:Endocytosis] |
germ cell development | biological process | The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism. [GOC:go_curators] |
spermatogenesis | biological process | The developmental process by which male germ line stem cells self renew or give rise to successive cell types resulting in the development of a spermatozoa. [GOC:jid, ISBN:9780878933846, PMID:28073824, PMID:30990821] |
male gonad development | biological process | The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure. [GOC:jid] |
apoptotic mitochondrial changes | biological process | The morphological and physiological alterations undergone by mitochondria during apoptosis. [GOC:mah, GOC:mtg_apoptosis] |
fertilization | biological process | The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy). [GOC:tb, ISBN:0198506732] |
regulation of cytokinesis | biological process | Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells. [GOC:mah] |
positive regulation of mononuclear cell proliferation | biological process | Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation. [GOC:add] |
ectopic germ cell programmed cell death | biological process | Programmed cell death of an errant germ line cell that is outside the normal migratory path or ectopic to the gonad. This is an important mechanism of regulating germ cell survival within the embryo. [PMID:12814944] |
regulation of growth | biological process | Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development. [GOC:ems, GOC:mah] |
negative regulation of apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
negative regulation of neuron apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. [GOC:go_curators, GOC:mtg_apoptosis] |
dendritic cell proliferation | biological process | The expansion of a dendritic cell population by cell division. A dendritic cell is a cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. [CL:0000451, PMID:18469816] |
response to cycloheximide | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes. [GOC:ef, ISBN:0198506732] |
regulation of mitochondrial membrane permeability | biological process | Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane. [GOC:bf] |
epithelial cell proliferation | biological process | The multiplication or reproduction of epithelial cells, resulting in the expansion of a cell population. Epithelial cells make up the epithelium, the covering of internal and external surfaces of the body, including the lining of vessels and other small cavities. It consists of cells joined by small amounts of cementing substances. [ISBN:0721662544] |
negative regulation of developmental process | biological process | Any process that stops, prevents or reduces the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). [GOC:ai] |
neuron apoptotic process | biological process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. [CL:0000540, GOC:mtg_apoptosis] |
defense response to virus | biological process | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. [GOC:ai] |
regulation of mitochondrial membrane potential | biological process | Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane. [GOC:ai] |
cellular response to amino acid stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups. [GOC:mah] |
cellular response to alkaloid | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active. [GOC:mah] |
cellular response to gamma radiation | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum. [GOC:mah] |
apoptotic process in bone marrow cell | biological process | The apoptotic process in cells in the bone marrow. [GOC:mah, GOC:mtg_apoptosis, PMID:17063141] |
negative regulation of release of cytochrome c from mitochondria | biological process | Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. [GOC:BHF, GOC:dph, GOC:mtg_apoptosis, GOC:tb] |
dendritic cell apoptotic process | biological process | Any apoptotic process in a dendritic cell, a cell of hematopoietic origin, typically resident in particular tissues, specialized in the uptake, processing, and transport of antigens to lymph nodes for the purpose of stimulating an immune response via T cell activation. [CL:0000451, GOC:BHF, GOC:mtg_apoptosis, PMID:15059845] |
hepatocyte apoptotic process | biological process | Any apoptotic process in a hepatocyte, the main structural component of the liver. [CL:0000182, GOC:jc, GOC:mtg_apoptosis, PMID:15856020] |
negative regulation of execution phase of apoptosis | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis. [GOC:mtg_apoptosis, GOC:TermGenie] |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage. [GOC:BHF, GOC:mtg_apoptosis, GOC:rl, GOC:TermGenie, PMID:15314165] |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway. [GOC:BHF, GOC:mtg_apoptosis, GOC:rl, GOC:TermGenie, PMID:20160352] |
negative regulation of protein localization to plasma membrane | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane. [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:11602640] |
negative regulation of reproductive process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of reproductive process. [GOC:mah] |
negative regulation of dendritic cell apoptotic process | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell apoptotic process. [GOC:mtg_apoptosis, GOC:obol] |
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. [GOC:mtg_apoptosis] |
negative regulation of intrinsic apoptotic signaling pathway | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway. [GOC:mtg_apoptosis] |
intrinsic apoptotic signaling pathway in response to DNA damage | biological process | The series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered. [GOC:go_curators, GOC:mtg_apoptosis] |
extrinsic apoptotic signaling pathway in absence of ligand | biological process | The series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered. [GOC:mtg_apoptosis, PMID:15044679, PMID:20816705] |
activation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. [GOC:al, GOC:dph, GOC:jl, GOC:mtg_apoptosis, GOC:tb, PMID:14744432, PMID:18328827, Wikipedia:Caspase] |